Ceva Santé Animale have appointed Dr Steve Chu to its executive committee with responsibility for all R&D activities.
Dr Chu joined Ceva in 2011 and has an outstanding record throughout his 30 year career in veterinary research, where he previously held senior research positions with Fort Dodge, Elanco and Pfizer animal health. He is known throughout the industry for his work in developing several first-of–its kind novel animal vaccines and received the CDC Director's Innovation Award for his contribution to the development of an Equine West Nile virus vaccine.
He will remain based in the US and add responsibility for global pharmaceutical research to his current role, where he successfully led Ceva's biology R&D.
To comment, login here
Or register to be able to comment.